Kuros Biosciences Ltd.
Develops biologic technologies for tissue repair and bone regeneration.
KURN | SW
Overview
Corporate Details
- ISIN(s):
- CH0325814116
- LEI:
- 5299006U5POB2AVTT709
- Country:
- Switzerland
- Address:
- Wagisstraße 25, 8952 Schlieren
- Website:
- https://kurosbio.com/
- Sector:
- Manufacturing
Description
Kuros Biosciences is a life sciences company that discovers, develops, and delivers innovative biologic technologies focused on tissue repair and bone regeneration. The company's mission is to address unmet clinical needs for safer, faster, and more predictable bone healing. Its primary commercial product is MagnetOs, an advanced bone graft designed to enhance bone formation. The efficacy of MagnetOs is supported by a comprehensive global research program, "Project Fusion," which includes scientific, pre-clinical, and Level I human clinical studies. Kuros Biosciences serves surgeons and patients across multiple medical fields, including spine, extremities, trauma, and oncology, leveraging deep scientific expertise and collaboration with leading clinical experts.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2012-10-09 07:00 |
Cytos Biotechnology Ltd appoints Dr. Christian Itin as Chief Executive Officer
|
English | 11.6 KB | ||
| 2012-07-30 07:00 |
Cytos Biotechnology Ltd Reports Second Quarter 2012 Financial Results, Recent D…
|
English | 10.7 KB | ||
| 2012-05-29 07:00 |
Cytos Biotechnology Ltd Nominates Dr. Christian Itin, former President and CEO …
|
English | 10.6 KB | ||
| 2012-05-18 07:00 |
Cytos Biotechnology Ltd Announces Updates to the Board of Directors
|
English | 10.0 KB | ||
| 2012-05-15 07:00 |
Cytos Biotechnology Ltd Completes the CHF 23.75 Million equity portion of its p…
|
English | 13.0 KB | ||
| 2012-05-10 20:30 |
Cytos Biotechnology Ltd. raises an additional CHF 3.2 million via Rights Offeri…
|
English | 8.3 KB | ||
| 2012-04-23 18:00 |
Cytos Biotechnology Ltd announces the terms and timetable of the rights issue o…
|
English | 10.2 KB | ||
| 2012-04-20 16:39 |
Annual Shareholder's Meeting of Cytos Biotechnology Ltd: Shareholders approve a…
|
English | 7.4 KB | ||
| 2012-04-20 07:00 |
Cytos gibt die Finanzzahlen fur das erste Quartal 2012 bekannt und ist zuversic…
|
German | 7.3 KB | ||
| 2012-04-04 07:00 |
Cytos Biotechnology Ltd: The application to grant an exception from the duty to…
|
English | 7.6 KB | ||
| 2012-03-29 17:31 |
Cytos invites for the Annual Shareholders' Meeting 2012
|
English | 6.5 KB | ||
| 2012-03-21 07:00 |
Cytos to raise up to CHF 37 million from international and strategic investors …
|
English | 18.4 KB | ||
| 2012-03-13 07:00 |
Bond restructuring final and binding. Going concern of Cytos ensured.
|
English | 6.9 KB | ||
| 2012-02-17 07:00 |
Cytos Biotechnology Ltd announces full year 2011 financial results
|
English | 5.1 KB | ||
| 2012-02-06 06:45 |
Cytos Biotechnology Ltd: Convertible bond restructuring proposal approved by th…
|
English | 6.9 KB |
Automate Your Workflow. Get a real-time feed of all Kuros Biosciences Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kuros Biosciences Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kuros Biosciences Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-23 | N/A | Executive member | Sell | None | 1,264,800.00 CHF |
| 2025-04-17 | N/A | Executive member | Sell | None | 13,344.49 CHF |
| 2025-03-18 | N/A | Non-Executive member | Buy | None | 38,200.00 CHF |
| 2024-12-11 | N/A | Executive member | Sell | None | 4,702,500.00 CHF |
| 2024-11-15 | N/A | Non-Executive member | Buy | None | 925,210.00 CHF |
| 2024-11-14 | N/A | Non-Executive member | Sell | None | 592,000.00 CHF |
| 2024-11-12 | N/A | Executive member | Sell | None | 13,890.86 CHF |
| 2024-09-25 | N/A | Executive member | Sell | None | 8,226,000.00 CHF |
| 2024-09-25 | N/A | Non-Executive member | Sell | None | 3,656,000.00 CHF |
| 2024-09-24 | N/A | Non-Executive member | Buy | None | 223,720.00 CHF |
Peer Companies
